---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-331596"
form_type: "8-K"
ticker: "ASPI"
cik: "0001921865"
company_name: "ASP Isotopes Inc."
filed_at: "2026-08-04T12:06:05+00:00"
generated_at: "2026-08-04T12:10:18.561473+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ASP Isotopes updates on PET Labs, helium, Silicon-28; Noble Africa merger with ENDRA on track

## Summary
- PET Labs 1H 2026 organic revenue growth >50% YoY; FY2026 revenue forecast ~$14M (up from $6M in 2025).
- Helium production at Renergen expected to commence before Sept 30, 2026; Phase 1 annualized revenue ~$27M.
- Noble Africa reverse merger with ENDRA (NDRA) expected to close in H2 2026; ASPI to own ~89% of combined company.
- Silicon-28 enrichment facility operating 48 stages; first commercial shipments of 99% enriched product expected in H2 2026.
- QLE convertible notes exchange: ~50% exchanged for ASPI common stock; remaining QLE notes ~$79.1M.

## SEC filing metadata
- accession: 0001193125-26-331596
- form_type: 8-K
- ticker: ASPI
- cik: 0001921865
- company_name: ASP Isotopes Inc.
- filed_at: 2026-08-04T12:06:05+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1921865/000119312526331596/0001193125-26-331596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1921865/000119312526331596/aspi-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-331596
- JSON: https://secwatch.observer/filing/0001193125-26-331596.json
- Plain text: https://secwatch.observer/filing/0001193125-26-331596.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.